SCHIFF ANDREW N
SEC CIK 1172252 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Dir | 25.5K | — | $3.65M | 11 | 2022-06-03 | 2026-06-05 |
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
| 13 | SCHIFF ANDREW N | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:15 | 2026-06-05 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | M - OptEx | — | +11.6K | 25.5K | +83% | — |
| D | 2025-06-09 | 2025-06-06 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | M - OptEx | — | +4,793 | 14.0K | +52% | — |
| D | 2024-06-04 | 2024-06-01 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | M - OptEx | — | +4,660 | 9,167 | +103% | — |
| D | 2023-06-05 | 2023-06-02 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | M - OptEx | — | +4,507 | 4,507 | New | — |
| MI | 2022-11-14 | 2022-11-10+ | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $17.05 | -53.9K | 434.5K | -11% | -$919.5K |
| MI | 2022-10-26 | 2022-10-24+ | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $17.01 | -41.2K | 502.9K | -8% | -$700.5K |
| MI | 2022-10-19 | 2022-10-17+ | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $16.57 | -52.0K | 561.6K | -8% | -$862.2K |
| I | 2022-10-11 | 2022-10-07 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $16.16 | -7,324 | 581.6K | -1% | -$118.4K |
| MI | 2022-10-06 | 2022-10-04+ | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $16.45 | -45.5K | 626.8K | -7% | -$749.1K |
| 2022-06-21 | 2022-06-17 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | S - Sale | $15.14 | -19.6K | 0 | -100% | -$296.2K | |
| D | 2022-06-06 | 2022-06-03 | ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Dir | M - OptEx | — | +3,356 | 19.6K | +21% | — |
Purchase Sale Sale after option exercise All abbreviations